CARGO Therapeutics, Inc. Common Stock (NASDAQ:CRGX) — Market Cap & Net Worth
Market Cap & Net Worth: CARGO Therapeutics, Inc. Common Stock (CRGX)
CARGO Therapeutics, Inc. Common Stock (NASDAQ:CRGX) has a market capitalization of $216.19 Million ($216.19 Million) as of May 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16237 globally and #3667 in its home market, demonstrating a 0.22% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CARGO Therapeutics, Inc. Common Stock's stock price $4.47 by its total outstanding shares 48364300 (48.36 Million). Analyse cash flow conversion of CARGO Therapeutics, Inc. Common Stock to see how efficiently the company converts income to cash.
CARGO Therapeutics, Inc. Common Stock Market Cap History: 2023 to 2025
CARGO Therapeutics, Inc. Common Stock's market capitalization history from 2023 to 2025. Data shows change from $1.12 Billion to $216.19 Million (-49.33% CAGR).
Index Memberships
CARGO Therapeutics, Inc. Common Stock is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.01% | #440 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #1578 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.67 Trillion | 0.01% | #224 of 263 |
Weight: CARGO Therapeutics, Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
CARGO Therapeutics, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CARGO Therapeutics, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CRGX by Market Capitalization
Companies near CARGO Therapeutics, Inc. Common Stock in the global market cap rankings as of May 5, 2026.
Key companies related to CARGO Therapeutics, Inc. Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
CARGO Therapeutics, Inc. Common Stock Historical Marketcap From 2023 to 2025
Between 2023 and today, CARGO Therapeutics, Inc. Common Stock's market cap moved from $1.12 Billion to $ 216.19 Million, with a yearly change of -49.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $216.19 Million | -69.00% |
| 2024 | $697.41 Million | -37.71% |
| 2023 | $1.12 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of CARGO Therapeutics, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $216.19 Million USD |
| MoneyControl | $216.19 Million USD |
| MarketWatch | $216.19 Million USD |
| marketcap.company | $216.19 Million USD |
| Reuters | $216.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CARGO Therapeutics, Inc. Common Stock
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, focused on designing, engineering, and developing potentially curative cell therapies for cancer patients in the United States. The company develops CRG-023, a tri-specific CAR T product candidate which is in phase 1 that targets tumor cells with three B-cell malignancies; and allogeneic platform, a universal vector solution design… Read more